{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:48:39Z","timestamp":1778507319598,"version":"3.51.4"},"reference-count":36,"publisher":"Walter de Gruyter GmbH","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2023-0169_abs_001\">\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Children with classical congenital adrenal hyperplasia (CAH) require glucocorticoid (GC) substitution due to impaired cortisol synthesis. To avoid over- or undertreatment, one has to consider auxology as well as biochemical parameters for adrenal derived steroids like androstenedione (A4) and 17-hydroxyprogesterone (17-OHP). There are no established reference values for A4 and 17-OHP in CAH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2023-0169_abs_002\">\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We performed a retrospective study in 53 prepubertal patients with CAH. Datasets of patients were included if the plasma A4 values of the respective clinical visit were under the limit of quantification. Related 17-OHP values were extracted as well as height\/length, weight, dose of hydrocortisone, HC regimen, bone age and stages of pubertal development.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2023-0169_abs_003\">\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Median hydrocortisone doses were in most observations within the recommended reference ranges. Hydrocortisone has a significant negative influence on 17-OHP values and HSDS. Age has a positive significant influence on 17-OHP, BMI-SDS, and HSDS. Median height standard-deviation-score (HSDS) was beneath 0 at all times, but showed an increasing trend in both sexes. Median body mass index standard-deviation-score (BMI-SDS) was above 0 at all times and showed an increasing trend as well.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2023-0169_abs_004\">\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>With guideline-compliant doses of hydrocortisone, suppression of A4 at the respective time of day is possible in prepubertal children. Although HC has a significant negative influence on HSDS, increasing values for HSDS and HC are observed with increasing age. Thus, A4 suppression at the respective time point does not hinder regular growth. An increase in body mass index can already be observed as early as in prepuberty.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2023-0169","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:06:27Z","timestamp":1693472787000},"page":"930-940","source":"Crossref","is-referenced-by-count":4,"title":["Effect of complete suppression of androstenedione on auxological development in prepubertal patients with classical congenital adrenal hyperplasia"],"prefix":"10.1515","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3952-0111","authenticated-orcid":false,"given":"Belana","family":"Debor","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetology, Dr. von Hauner Children\u2019s Hospital , University Hospital Munich, LMU Munich , Munich , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Bechtold-Dalla Pozza","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetology, Dr. von Hauner Children\u2019s Hospital , University Hospital Munich, LMU Munich , Munich , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[{"name":"Department of Medicine IV , University Hospital, LMU Munich , Munich , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Schmidt","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetology, Dr. von Hauner Children\u2019s Hospital , University Hospital Munich, LMU Munich , Munich , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-2453","authenticated-orcid":false,"given":"Ilja","family":"Dubinski","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology and Diabetology, Dr. von Hauner Children\u2019s Hospital , University Hospital Munich, LMU Munich , Munich , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"2023100615123192086_j_jpem-2023-0169_ref_001","doi-asserted-by":"crossref","unstructured":"El-Maouche, D, Arlt, W, Merke, DP. Congenital adrenal hyperplasia. Lancet 2017;390:2194\u2013210. https:\/\/doi.org\/10.1016\/s0140-6736(17)31431-9.","DOI":"10.1016\/S0140-6736(17)31431-9"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_002","doi-asserted-by":"crossref","unstructured":"White, PC, Speiser, PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245\u201391. https:\/\/doi.org\/10.1210\/edrv.21.3.0398.","DOI":"10.1210\/edrv.21.3.0398"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_003","doi-asserted-by":"crossref","unstructured":"Gidl\u00f6f, S, Falhammar, H, Thil\u00e9n, A, von D\u00f6beln, U, Ritz\u00e9n, M, Wedell, A, et al.. One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol 2013;1:35\u201342. https:\/\/doi.org\/10.1016\/s2213-8587(13)70007-x.","DOI":"10.1016\/S2213-8587(13)70007-X"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_004","doi-asserted-by":"crossref","unstructured":"Claahsen-van der Grinten, HL, Speiser, PW, Ahmed, SF, Arlt, W, Auchus, RJ, Falhammar, H, et al.. Congenital adrenal hyperplasia-current insights in pathophysiology, diagnostics, and management. Endocr Rev 2022;43:91\u2013159. https:\/\/doi.org\/10.1210\/endrev\/bnab016.","DOI":"10.1210\/endrev\/bnab016"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_005","doi-asserted-by":"crossref","unstructured":"Merke, DP, Auchus, RJ. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 2020;383:1248\u201361. https:\/\/doi.org\/10.1056\/nejmra1909786.","DOI":"10.1056\/NEJMra1909786"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_006","doi-asserted-by":"crossref","unstructured":"Speiser, PW, Arlt, W, Auchus, RJ, Baskin, LS, Conway, GS, Merke, DP, et al.. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2018;103:4043\u201388. https:\/\/doi.org\/10.1210\/jc.2018-01865.","DOI":"10.1210\/jc.2018-01865"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_007","doi-asserted-by":"crossref","unstructured":"Allen, DB. Growth suppression by glucocorticoid therapy. Endocrinol Metab Clin N Am 1996;25:699\u2013717. https:\/\/doi.org\/10.1016\/s0889-8529(05)70348-0.","DOI":"10.1016\/S0889-8529(05)70348-0"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_008","doi-asserted-by":"crossref","unstructured":"Hochberg, Z. Mechanisms of steroid impairment of growth. Horm Res 2002;58:33\u20138. https:\/\/doi.org\/10.1159\/000064764.","DOI":"10.1159\/000064764"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_009","doi-asserted-by":"crossref","unstructured":"Van der Kamp, HJ, Otten, BJ, Buitenweg, N, De Muinck Keizer-Schrama, SM, Oostdijk, W, Jansen, M, et al.. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients. Arch Dis Child 2002;87:139\u201344. https:\/\/doi.org\/10.1136\/adc.87.2.139.","DOI":"10.1136\/adc.87.2.139"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_010","doi-asserted-by":"crossref","unstructured":"Bonfig, W, Pozza, SBD, Schmidt, H, Pagel, P, Knorr, D, Schwarz, HP. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation. J\u00a0Clin Endocrinol Metab 2009;94:3882\u20138. https:\/\/doi.org\/10.1210\/jc.2009-0942.","DOI":"10.1210\/jc.2009-0942"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_011","doi-asserted-by":"crossref","unstructured":"Balsamo, A, Wasniewska, M, Di Pasquale, G, Salzano, G, Baronio, F, Bombaci, S, et al.. Birth length and weight in congenital adrenal hyperplasia according to the different phenotypes. Eur J Pediatr 2006;165:380\u20133. https:\/\/doi.org\/10.1007\/s00431-005-0075-y.","DOI":"10.1007\/s00431-005-0075-y"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_012","doi-asserted-by":"crossref","unstructured":"Bonfig, W, Schmidt, H, Schwarz, HP. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone. Horm Res Paediatr 2011;75:32\u20137. https:\/\/doi.org\/10.1159\/000316973.","DOI":"10.1159\/000316973"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_013","doi-asserted-by":"crossref","unstructured":"Thil\u00e9n, A, Woods, KA, Perry, LA, Savage, MO, Wedell, A, Ritz\u00e9n, EM. Early growth is not increased in untreated moderately severe 21-hydroxylase deficiency. Acta Paediatr 1995;84:894\u20138. https:\/\/doi.org\/10.1111\/j.1651-2227.1995.tb13788.x.","DOI":"10.1111\/j.1651-2227.1995.tb13788.x"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_014","doi-asserted-by":"crossref","unstructured":"Claahsen-van der Grinten, HL, Noordam, K, Borm, GF, Otten, BJ. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 2006;91:1205\u20139. https:\/\/doi.org\/10.1210\/jc.2005-1701.","DOI":"10.1210\/jc.2005-1701"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_015","doi-asserted-by":"crossref","unstructured":"Bonfig, W, Schwarz, HP. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life. Horm Res Paediatr 2011;75:264\u20138. https:\/\/doi.org\/10.1159\/000322580.","DOI":"10.1159\/000322580"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_016","doi-asserted-by":"crossref","unstructured":"Kawano, A, Kohno, H, Miyako, K. A retrospective analysis of the growth pattern in patients with salt-wasting 21-hydroxylase deficiency. Clin Pediatr Endocrinol 2014;23:27\u201334. https:\/\/doi.org\/10.1297\/cpe.23.27.","DOI":"10.1297\/cpe.23.27"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_017","doi-asserted-by":"crossref","unstructured":"Manoli, I, Kanaka-Gantenbein, C, Voutetakis, A, Maniati-Christidi, M, Dacou-Voutetakis, C. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome. Clin Endocrinol 2002;57:669\u201376. https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01645.x.","DOI":"10.1046\/j.1365-2265.2002.01645.x"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_018","doi-asserted-by":"crossref","unstructured":"Grigorescu-Sido, A, Bettendorf, M, Schulze, E, Duncea, I, Heinrich, U. Growth analysis in patients with 21-hydroxylase deficiency influence of glucocorticoid dosage, age at diagnosis, phenotype and genotype on growth and height outcome. Horm Res 2003;60:84\u201390. https:\/\/doi.org\/10.1159\/000071876.","DOI":"10.1159\/000071876"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_019","doi-asserted-by":"crossref","unstructured":"Bonfig, W, Bechtold, S, Schmidt, H, Knorr, D, Schwarz, HP. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty. J Clin Endocrinol Metab 2007;92:1635\u20139. https:\/\/doi.org\/10.1210\/jc.2006-2109.","DOI":"10.1210\/jc.2006-2109"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_020","doi-asserted-by":"crossref","unstructured":"Kushnir, MM, Blamires, T, Rockwood, AL, Roberts, WL, Yue, B, Erdogan, E, et al.. Liquid chromatography-tandem mass spectrometry assay for androstenedione, dehydroepiandrosterone, and testosterone with pediatric and adult reference intervals. Clin Chem 2010;56:1138\u201347. https:\/\/doi.org\/10.1373\/clinchem.2010.143222.","DOI":"10.1373\/clinchem.2010.143222"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_021","doi-asserted-by":"crossref","unstructured":"Merke, DP, Bornstein, SR. Congenital adrenal hyperplasia. Lancet 2005;365:2125\u201336. https:\/\/doi.org\/10.1016\/s0140-6736(05)66736-0.","DOI":"10.1016\/S0140-6736(05)66736-0"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_022","doi-asserted-by":"crossref","unstructured":"Troger, T, Sommer, G, Lang-Muritano, M, Konrad, D, Kuhlmann, B, Zumsteg, U, et al.. Characteristics of growth in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency during adrenarche and beyond. J Clin Endocrinol Metab 2022;107:e487\u201399. https:\/\/doi.org\/10.1210\/clinem\/dgab701.","DOI":"10.1210\/clinem\/dgab701"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_023","doi-asserted-by":"crossref","unstructured":"Greulich, WW, Pyle, SI. Radiographic atlas of skeletal development of the hand and wrist. Stanford, California, USA: Stanford University Press; 1959.","DOI":"10.1097\/00000441-195909000-00030"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_024","doi-asserted-by":"crossref","unstructured":"DuBois, D, DuBois, EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863\u201371. https:\/\/doi.org\/10.1001\/archinte.1916.00080130010002.","DOI":"10.1001\/archinte.1916.00080130010002"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_025","unstructured":"Prader, A, Largo, RH, Molinari, L, Issler, C. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl 1989;52:1\u2013125."},{"key":"2023100615123192086_j_jpem-2023-0169_ref_026","doi-asserted-by":"crossref","unstructured":"Kromeyer-Hauschild, K, Wabitsch, M, Kunze, D, Geller, F, Gei\u00df, HC, Hesse, V, et al.. Perzentile f\u00fcr den Body-mass-Index f\u00fcr das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001;149:807\u201318. https:\/\/doi.org\/10.1007\/s001120170107.","DOI":"10.1007\/s001120170107"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_027","doi-asserted-by":"crossref","unstructured":"D\u00f6rr, HG. Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 2007;68(Suppl 5):93\u20139. https:\/\/doi.org\/10.1159\/000110587.","DOI":"10.1159\/000110587"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_028","doi-asserted-by":"crossref","unstructured":"Hargitai, G, S\u00f3lyom, J, Battelino, T, Lebl, J, Pribilincov\u00e1, Z, Hauspie, R, et al.. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study. Horm Res 2001;55:161\u201371. https:\/\/doi.org\/10.1159\/000049990.","DOI":"10.1159\/000049990"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_029","doi-asserted-by":"crossref","unstructured":"Cabrera, MS, Vogiatzi, MG, New, MI. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001;86:3070\u20138. https:\/\/doi.org\/10.1210\/jc.86.7.3070.","DOI":"10.1210\/jc.86.7.3070"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_030","doi-asserted-by":"crossref","unstructured":"Odenwald, B, Nennstiel-Ratzel, U, D\u00f6rr, HG, Schmidt, H, Wildner, M, Bonfig, W. Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life. Eur J Endocrinol 2016;174:177\u201386. https:\/\/doi.org\/10.1530\/eje-15-0775.","DOI":"10.1530\/EJE-15-0775"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_031","doi-asserted-by":"crossref","unstructured":"Stikkelbroeck, NM, Van\u2019t Hof-Grootenboer, BA, Hermus, AR, Otten, BJ, Van\u2019t Hof, MA. Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre)puberty. J\u00a0Clin Endocrinol Metab 2003;88:3525\u201330. https:\/\/doi.org\/10.1210\/jc.2002-030011.","DOI":"10.1210\/jc.2002-030011"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_032","doi-asserted-by":"crossref","unstructured":"Al-Kofahi, M, Ahmed, MA, Jaber, MM, Tran, TN, Willis, BA, Zimmerman, CL, et al.. An integrated PK-PD model for cortisol and the 17-hydroxyprogesterone and androstenedione biomarkers in children with congenital adrenal hyperplasia. Br J Clin Pharmacol 2021;87:1098\u2013110. https:\/\/doi.org\/10.1111\/bcp.14470.","DOI":"10.1111\/bcp.14470"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_033","doi-asserted-by":"crossref","unstructured":"Dubinski, I, Bechtold, S, Bidlingmaier, M, Reisch, N, Schmidt, H. Salivary 17-hydroxyprogesterone levels in children with congenital adrenal hyperplasia: a retrospective longitudinal study considering auxological parameters. Horm Res Paediatr 2023;96:259\u201366. https:\/\/doi.org\/10.1159\/000526485.","DOI":"10.1159\/000526485"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_034","doi-asserted-by":"crossref","unstructured":"Brunelli, VL, Chiumello, G, David, M, Forest, MG. Adrenarche does not occur in treated patients with congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency. Clin Endocrinol 1995;42:461\u20136. https:\/\/doi.org\/10.1111\/j.1365-2265.1995.tb02663.x.","DOI":"10.1111\/j.1365-2265.1995.tb02663.x"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_035","doi-asserted-by":"crossref","unstructured":"Sellers, EP, MacGillivray, MH. Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Res 1995;21:537\u201344. https:\/\/doi.org\/10.1080\/07435809509030471.","DOI":"10.1080\/07435809509030471"},{"key":"2023100615123192086_j_jpem-2023-0169_ref_036","doi-asserted-by":"crossref","unstructured":"V\u00f6lkl, TM, \u00d6hl, L, Rauh, M, Sch\u00f6fl, C, D\u00f6rr, HG. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res Paediatr 2011;76:400\u201310. https:\/\/doi.org\/10.1159\/000333696.","DOI":"10.1159\/000333696"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2023-0169\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2023-0169\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T15:14:01Z","timestamp":1696605241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2023-0169\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,8,28]]},"published-print":{"date-parts":[[2023,10,26]]}},"alternative-id":["10.1515\/jpem-2023-0169"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2023-0169","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}